Analysis of plasma biomarker and tumor genetic alterations from a phase II trial of lenvatinib in patients with advanced endometrial cancer.
Yasuhiro Funahashi
Employment or Leadership Position - Eisai
Stock Ownership - Eisai
Richard T. Penson
Other Remuneration - Protocol Dev. Co.
Matthew A. Powell
Consultant or Advisory Role - Arno Therapeutics; Eisai; Genentech/Roche; GlaxoSmithKline; Novartis
Honoraria - Ethicon; Merck
David S. Miller
Consultant or Advisory Role - Eisai
Research Funding - Eisai
Jean Fan
Employment or Leadership Position - Eisai
Min Ren
Employment or Leadership Position - Eisai
Nicole Meneses
Employment or Leadership Position - Eisai
Pallavi Sachdev
Employment or Leadership Position - Eisai
Tadashi Kadowaki
Employment or Leadership Position - Eisai
Stock Ownership - Eisai
James P. O'Brien
Employment or Leadership Position - Eisai
Ignace Vergote
Consultant or Advisory Role - Eisai
Honoraria - Eisai